December 9, 2015
Novartis delivers 300M pediatric antimalarial no-profit-treatments since 2009
Novartis has reached a delivery milestone of 300 million pediatric antimalarial treatments supplied without profit since 2009, helping to reduce the disease burden for children in more than 30 malaria-endemic countries.